Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors

Summary

In this study, individuals without hepatitis C infection who are on the kidney transplant waitlist will receive a kidney from a deceased donor with hepatitis C infection and will be treated for hepatitis C at the same time. Treatment will include glecaprevir 300 mg / pibrentasvir 120 mg (G-P) administered on-call to the operating room for the renal transplant procedure and continued for 4 weeks post-renal transplant.

Timeline

Start

2018-09-25

Primary completion

2019-12-19

Completion

2021-09-20

Drugs

Indications